ABSTRACT
Fungal infections are a global problem imposing considerable disease burden. One of the unmet needs in addressing these infections is rapid, sensitive diagnostics. A promising molecular diagnostic approach is high-resolution melt analysis (HRM). However, there has been little effort in leveraging HRM data for automated, objective identification of fungal species. The purpose of these studies was to assess the utility of distance methods developed for comparison of time series data to classify HRM curves as a means of fungal species identification. Dynamic time warping (DTW), first introduced in the context of speech recognition to identify temporal distortion of similar sounds, is an elastic distance measure that has been successfully applied to a wide range of time series data. Comparison of HRM curves of the rDNA internal transcribed spacer (ITS) region from 51 strains of 18 fungal species using DTW distances allowed accurate classification and clustering of all 51 strains. The utility of DTW distances for species identification was demonstrated by matching HRM curves from 243 previously identified clinical isolates against a database of curves from standard reference strains. The results revealed a number of prior misclassifications, discriminated species that are not resolved by routine phenotypic tests, and accurately identified all 243 test strains. In addition to DTW, several other distance functions, Edit Distance on Real sequence (EDR) and Shape-based Distance (SBD), showed promise. It is concluded that DTW-based distances provide a useful metric for the automated identification of fungi based on HRM curves of the ITS region and that this provides the foundation for a robust and automatable method applicable to the clinical setting.
Subject(s)
Fungi/classification , Fungi/genetics , Mycoses/diagnosis , Mycoses/microbiology , Nucleic Acid Amplification Techniques , Cluster Analysis , DNA, Ribosomal , Humans , Polymerase Chain Reaction/methods , Transition TemperatureABSTRACT
Human herpesvirus-6 (HHV-6)A and 6B are ubiquitous betaherpesviruses viruses with lymphotropic and neurotropic potential. As reported earlier, these viruses establish latency by integration into the telomeres of host chromosomes. Chromosomally integrated HHV-6 (CIHHV-6) can be transmitted vertically from parent to child. Some CIHHV-6 patients are suffering from neurological symptoms, while others remain asymptomatic. Four patients with CIHHV-6 and CNS dysfunction were treated with valganciclovir or foscarnet. HHV-6 replication was detected by reverse transcriptase polymerase chain reaction amplification of a late envelope glycoprotein. In this study we also compared the inherited and persistent HHV-6 viruses by DNA sequencing. The prevalence of CIHHV-6 in this cohort of adult patients from the USA suffering from a wide range of neurological symptoms including long-term fatigue were found significantly greater than the reported 0.8% in the general population. Long-term antiviral therapy inhibited HHV-6 replication as documented by loss of viral mRNA production. Sequence comparison of the mRNA and the inherited viral genome revealed that the transcript is produced by an exogenous virus. In conclusion, the data presented here document that some individuals with CIHHV-6 are infected persistently with exogenous HHV-6 strains that lead to a wide range of neurological symptoms; the proposed name for this condition is inherited herpesvirus 6 syndrome or IHS.
Subject(s)
Herpesvirus 6, Human/isolation & purification , Infectious Disease Transmission, Vertical , Roseolovirus Infections/transmission , Roseolovirus Infections/virology , Adult , Antiviral Agents/administration & dosage , Cohort Studies , DNA, Viral/genetics , Foscarnet/administration & dosage , Ganciclovir/administration & dosage , Ganciclovir/analogs & derivatives , Herpesvirus 6, Human/physiology , Humans , Prevalence , RNA, Viral/genetics , Roseolovirus Infections/epidemiology , Roseolovirus Infections/pathology , Sequence Analysis, DNA , Treatment Outcome , United States/epidemiology , Valganciclovir , Virus Replication/drug effectsABSTRACT
Tumor associated antigens from pooled allogeneic membrane proteins were isolated, partially purified and tested as a possible vaccine in patients with stage II and III colon cancer. The vaccine, when given in combination with an adjuvant following surgical resection, resulted in marked improvement in survival compared to control patients having only undergone surgical resection of their tumor. While it was possible to demonstrate that patients receiving vaccine turned on both humoral and cell mediated responses, it appears that survivors remaining free of disease at 5-7 yrs post op were able to mount a strong IgG1 response as the primary mechanism for tumor destruction. Antibodies from hybridomas made against the vaccines resulted in production of monoclonals with a high degree of ADCC. Those monoclonals targeting pancreatic cancer and in particular the MUC5ac mutated antigen representing tumor immunogen were studied in detail. Animal models indicated rapid tumor destruction when nude mice, injected with human pancreatic cancer were then immunized with NPC-1 monoclonal antibody targeting mutated MUC5ac. FDA studies including tissue cross reactivity, biodistribution, and cytokine release assays indicated safety and efficacy of the monoclonals we have developed. Submission of the IND allowed for initiation of the Phase I trial using mAb NPC-1 targeting pancreatic cancer when that antigen was found to be expressed.
Subject(s)
Antibodies, Monoclonal/therapeutic use , Antigens, Neoplasm/immunology , Colonic Neoplasms/therapy , Pancreatic Neoplasms/therapy , Animals , Cancer Vaccines/immunology , Colonic Neoplasms/pathology , Humans , Hybridomas , Membrane Proteins/immunology , Mice , Mice, Nude , Pancreatic Neoplasms/pathology , Xenograft Model Antitumor AssaysABSTRACT
A serum ELISA using a monoclonal antibody that detects a MUC5AC-related antigen (NPC-1C antigen) expressed by pancreatic and colorectal cancer was developed. The NPC-1C antibody reacts with specific epitopes expressed by tumor-associated MUC5AC that does not appear on MUC5AC from normal tissues. Based on observations of a highly specific antibody, we tested the ELISA to differentiate serum from healthy blood donors compared to serum from patients with colorectal or pancreatic cancer. Additionally, patient tumor tissue was stained to examine the expression pattern of MUC5AC-related antigen in pancreatic and colorectal cancers. The results indicate the NPC-1C antibody ELISA distinguished serum of cancer patients from normal donors with very good sensitivity and specificity. Most patient's tumor biopsy exhibited NPC-1C antibody reactivity, indicating that tumor-associated MUC5AC antigen from tumor is shed into blood, where it can be detected by the NPC-1C antibody ELISA. This serum test provides a new tool to aid in the diagnosis of these cancers and immune monitoring of cancer treatment regimens.
Subject(s)
Biomarkers, Tumor/blood , Enzyme-Linked Immunosorbent Assay/methods , Mucin 5AC/classification , Antibodies, Monoclonal/chemistry , Colorectal Neoplasms/blood , Humans , Immunohistochemistry , Mucin 5AC/blood , Mucin 5AC/chemistry , Pancreatic Neoplasms/bloodABSTRACT
Previous research has suggested that human herpesvirus-6 (HHV-6) may integrate into host cell chromosomes and be vertically transmitted in the germ line, but the evidence--primarily fluorescence in situ hybridization (FISH)--is indirect. We sought, first, to definitively test these two hypotheses. Peripheral blood mononuclear cells (PBMCs) were isolated from families in which several members, including at least one parent and child, had unusually high copy numbers of HHV-6 DNA per milliliter of blood. FISH confirmed that HHV-6 DNA colocalized with telomeric regions of one allele on chromosomes 17p13.3, 18q23, and 22q13.3, and that the integration site was identical among members of the same family. Integration of the HHV-6 genome into TTAGGG telomere repeats was confirmed by additional methods and sequencing of the integration site. Partial sequencing of the viral genome identified the same integrated HHV-6A strain within members of families, confirming vertical transmission of the viral genome. We next asked whether HHV-6A infection of naïve cell lines could lead to integration. Following infection of naïve Jjhan and HEK-293 cell lines by HHV-6, the virus integrated into telomeres. Reactivation of integrated HHV-6A virus from individuals' PBMCs as well as cell lines was successfully accomplished by compounds known to induce latent herpesvirus replication. Finally, no circular episomal forms were detected even by PCR. Taken together, the data suggest that HHV-6 is unique among human herpesviruses: it specifically and efficiently integrates into telomeres of chromosomes during latency rather than forming episomes, and the integrated viral genome is capable of producing virions.
Subject(s)
Chromosomes, Human/genetics , Chromosomes, Human/virology , Herpesvirus 6, Human/genetics , Herpesvirus 6, Human/pathogenicity , Telomere/genetics , Telomere/virology , Virus Integration/genetics , Adult , Aged , Aged, 80 and over , Base Sequence , Cell Line , Child , DNA, Viral/blood , DNA, Viral/genetics , Female , Gene Dosage , Genome, Viral , Germ Cells/virology , Herpesvirus 6, Human/physiology , Humans , In Situ Hybridization, Fluorescence , In Vitro Techniques , Infectious Disease Transmission, Vertical , Male , Middle Aged , Molecular Sequence Data , Plasmids/blood , Plasmids/genetics , Roseolovirus Infections/genetics , Roseolovirus Infections/transmission , Roseolovirus Infections/virology , Virus Activation , Virus Replication , Young AdultABSTRACT
BACKGROUND: The human endogenous retrovirus K-18 (HERV-K18) encodes a superantigen that causes deregulation of the immune system. This provirus is transcriptionally silent, but can be induced by Epstein-Barr virus (EBV) infection and IFN-alpha treatment. OBJECTIVES: Since the herpesvirus EBV induces HERV-K18 expression in human B cells, it was of interest to determine if other herpesviruses would have similar HERV-K18 transactivation properties. Human herpesvirus (HHV)-6A, a neurotropic virus associated with multiple sclerosis, was a logical candidate for these studies. STUDY DESIGN: HSB2 cells (HHV-6-negative control), HSB2-ML cells (containing latent HHV-6A genome) and HSB2/HHV-6A cells (HSB-2 cells productively infected with HHV-6A) were compared for their level of HERV-K18 transcription, using quantitative RT-PCR. RESULTS: Latently infected HSB2-ML cells showed a significant increase in HERV-K18 RNA compared to the control cells. HERV-K18 expression was even greater in HSB2 cells productively infected with HHV-6A for 78h. CONCLUSION: These results imply that HHV-6A, either in latent form or during acute infection, directly transactivates HERV-K18. This HERV-K18 induction may be mediated through IFN-alpha that is produced by the HHV-6A-infected cells. The functional implications of superantigen expression are discussed.
Subject(s)
Endogenous Retroviruses/physiology , Gene Expression Profiling , Herpesvirus 6, Human/physiology , Membrane Proteins/biosynthesis , Superantigens/biosynthesis , Cell Line , Humans , Membrane Proteins/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , RNA, Viral/biosynthesis , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Superantigens/geneticsABSTRACT
Direct nerve-to-muscle neurotization has been the subject of both clinical and experimental studies. In this study, the authors report a new animal model to test the regenerative properties of a nerve (musculocutaneous) implanted in a muscle (biceps). They also report the early effects of the application at the implantation site of exogenously administered Brain Derived Nerve Factor (BDNF) and of endogenously produced BDNF, via the administration of an adenoviral construct with a tissue-specific promotor for muscle cells (AdRSV), and containing the BDNF gene. Evaluation included behavioral testing (grooming test), electrical stimulation, Western blot analysis of the distal implanted nerve to determine the presence of locally produced BDNF, and motor end-plate staining of the biceps muscle. At the early time point of 1 week following the musculocutaneous nerve to biceps muscle implantation, there was no increased production of recombinant BDNF at the distal implanted musculocutaneous nerve, as assessed by Western blot analysis. Therefore, there was no significant difference in the behavioral evaluation of the animals at 1 week; the Terzis grooming test showed no statistical difference among groups, but a trend toward better function for the BDNF and the high-dose AdRSV-BDNF groups, compared to the control groups. There was also no difference in the histologic appearance and number of the motor end-plates at the implantation site, compared to the controls. The electrical stimulation of the MC nerve did not produce statistically significant results among the experimental groups. In this direct nerve to muscle neurotization model, the application of AdRSV-BDNF at 3 x 10 (9) pfu/ul did not show enhanced production of BDNF at 1 week.
Subject(s)
Brain-Derived Neurotrophic Factor/administration & dosage , Genetic Therapy/methods , Growth Substances/administration & dosage , Nerve Regeneration/drug effects , Nerve Transfer/methods , Adenoviridae , Animals , Genetic Vectors , Male , Models, Animal , Muscle, Skeletal , Rats , Rats, Sprague-DawleyABSTRACT
Los virus linfotrópicos herpes humanos ejercen un efecto dual en el sistema inmune: estimulan como antígenos e interfieren funcionalmente debido a sulinfotropismo. En consecuencias, pueden resultar diferentes enfermedades, o verse éstas influenciadas en su evolución, posterior a la reactivación o persistencia de dichos virus. Los efectos son modulados por la edad del afectado y mediante la actividad variable del sistema de defensa humano. Los patrones de enfermedad asociados con estos virus van desde aproliferativos (aplásticos) hasta proliferativos (neoplásicos) y desórdenes autoinmunes. Esta revisión resume los conceptos e hipótesis actuales